Cargando…

Incidence of non-invasive all-cause pneumonia in children in the United States before and after the introduction of pneumococcal conjugate vaccines: a retrospective claims database analysis

BACKGROUND: Pneumonia is the most serious form of acute respiratory infection and Streptococcus pneumoniae is a leading cause of pediatric bacterial pneumonia. Pneumococcal conjugate vaccines were introduced in the United States (US) in 2000 (7-valent [PCV7]) and 2010 (13-valent [PCV13]). This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Tianyan, Sarpong, Eric M., Song, Yan, Done, Nicolae, Liu, Qing, Lemus-Wirtz, Esteban, Signorovitch, James, Mohanty, Salini, Weiss, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074783/ https://www.ncbi.nlm.nih.gov/pubmed/37016411 http://dx.doi.org/10.1186/s41479-023-00109-5

Ejemplares similares

Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018
por: Hu, Tianyan, et al.
Publicado: (2022)

Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018
por: Hu, Tianyan, et al.
Publicado: (2022)

Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014–2018
por: Hu, Tianyan, et al.
Publicado: (2023)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

1479. Incidence of Acute Otitis Media in Children in the United States before and after the introduction of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

1693. Incidence of Pneumococcal Disease in Children ≤48 Months Old in the United States: 2010-2019
por: Mohanty, Salini, et al.
Publicado: (2023)

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong
por: Mohanty, Salini, et al.
Publicado: (2022)

Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine
por: Moïsi, Jennifer C., et al.
Publicado: (2017)

Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
por: Turner, Paul, et al.
Publicado: (2015)

A Pneumococcal Carriage Study in Danish Pre-school Children before the Introduction of Pneumococcal Conjugate Vaccination
por: Harboe, Zitta B, et al.
Publicado: (2012)

Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination
por: Heinsbroek, Ellen, et al.
Publicado: (2018)

All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States
por: Mostaghimi, Arash, et al.
Publicado: (2022)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
por: Richter, Sandra S., et al.
Publicado: (2013)

Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000–2019: protocol for systematic review
por: Kalata, Newton L., et al.
Publicado: (2019)

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
por: Mohanty, Salini, et al.
Publicado: (2023)

Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model
por: Papp, Kim A., et al.
Publicado: (2021)

Multiple Colonization with S. pneumoniae before and after Introduction of the Seven-Valent Conjugated Pneumococcal Polysaccharide Vaccine
por: Brugger, Silvio D., et al.
Publicado: (2010)

Piliation of Invasive Streptococcus pneumoniae Isolates in the Era before Pneumococcal Conjugate Vaccine Introduction in Malawi
por: Kulohoma, Benard W., et al.
Publicado: (2013)

Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program
por: Richter, Lukas, et al.
Publicado: (2019)

Healthcare resource utilisation and cost of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
por: Mohanty, Salini, et al.
Publicado: (2023)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Nasopharyngeal colonization of Gambian infants by Staphylococcus aureus and Streptococcus pneumoniae before the introduction of pneumococcal conjugate vaccines
por: Usuf, E., et al.
Publicado: (2015)

Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program
por: Richter, Lukas, et al.
Publicado: (2019)

Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines
por: Sanneh, Bakary, et al.
Publicado: (2019)

Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines
por: Adamkiewicz, Thomas V., et al.
Publicado: (2023)

Serotype Distribution of Clinical Streptococcus pneumoniae Isolates before the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Cambodia
por: Inghammar, Malin, et al.
Publicado: (2018)

Pediatric Community- Acquired Bacteremia Before and After the Introduction of the Pneumococcal Conjugate Vaccine into the National Immunization Program in Israel
por: Berger, Yael, et al.
Publicado: (2017)

Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine
por: Elemraid, Mohamed A., et al.
Publicado: (2013)

Progress in Introduction of Pneumococcal Conjugate Vaccine — Worldwide, 2000–2012
por: Wang, Susan A., et al.
Publicado: (2013)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
por: Patel, Sweta M., et al.
Publicado: (2022)

Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine—Burkina Faso, 2011–2013
por: Kambiré, Dinanibè, et al.
Publicado: (2016)

Invasive pneumococcal disease in hospitalised children from Lima, Peru before and after introduction of the 7-valent conjugated vaccine
por: Luna-Muschi, A., et al.
Publicado: (2019)

Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa
por: von Mollendorf, Claire, et al.
Publicado: (2017)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: Knol, Mirjam J., et al.
Publicado: (2015)

Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis
por: Caceres, Diana C., et al.
Publicado: (2018)

Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children
por: Takeda, Hiroaki, et al.
Publicado: (2019)

Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine
por: Paulo, Ana Cristina, et al.
Publicado: (2017)

Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants
por: Lin, Nancy D, et al.
Publicado: (2005)

High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction
por: Conklin, Laura M., et al.
Publicado: (2016)

All-Cause Pneumonia Hospitalizations in Children <2 Years Old in Sweden, 1998 to 2012: Impact of Pneumococcal Conjugate Vaccine Introduction
por: Berglund, Anders, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ntd3e6epi0dlk1d41tru1k20qj